Bivalent Ligands Derived from Huperzine A as Acetylcholinesterase Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|7|4|375-387

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.7, Iss.4, 2007-02, pp. : 375-387

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Bivalent Acetylcholinesterase Inhibitors as Potential Therapeutic Drugs for Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 10, Iss. 25, 2004-10 ,pp. : 3141-3156

Bentham Science Publishers

Access to resources Recommend Favorite

From Dual Binding Site Acetylcholinesterase Inhibitors to Multi-Target-Directed Ligands (MTDLs): A Step Forward in the Treatment of Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 10, 2008-09 ,pp. : 960-967

Bentham Science Publishers

Access to resources Recommend Favorite

Tacrine-Huperzine A Hybrids (Huprines) A New Class of Highly Potent and Selective Acetylcholinesterase Inhibitors of Interest for the Treatment of Alzheimer Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 2, 2001-07 ,pp. : 163-174

Bentham Science Publishers

Access to resources Recommend Favorite

Biphalin: The Foundation of Bivalent Ligands

By  

Current Medicinal Chemistry, Vol. 23, Iss. 29, 2016-10 ,pp. : 3267-3284

Bentham Science Publishers

Access to resources Recommend Favorite

Kappa Receptor Bivalent Ligands

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 4, 2007-02 ,pp. : 363-373

Bentham Science Publishers

Access to resources Recommend Favorite